If you liked this article you might like

5 Small-Cap Biotechs With Big Potential
Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Investors Scour Big Pharma M&A Scene for Next Big Takeover
Progenics Pharmaceuticals (PGNX) Is Today's Perilous Reversal Stock